Brain Neoplasm
38
4
6
18
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
10.5%
4 terminated out of 38 trials
81.8%
-4.7% vs benchmark
5%
2 trials in Phase 3/4
22%
4 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (38)
Tumor Related Epilepsy
Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma
Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy
MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Use of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness Measurements
Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors
Surgical Resection of Latent Brain Tumors Prior to Recurrence
Non-invasive Intracranial Pressure Monitoring in Brain Tumor Patients
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
Measuring Brain Tumor Consistency Using Magnetic Resonance Elastography
Cryoablation of Brain Neoplasm
Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions
Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors
Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
Single Dose Tramadol Effect on Extubation Response and Quality of Emergence Post-supratentorial Intracranial Surgery
Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors